CO6150136A2 - Combinacion de adapaleno y peroxido de benzoilo para tratar lesiones de acne - Google Patents
Combinacion de adapaleno y peroxido de benzoilo para tratar lesiones de acneInfo
- Publication number
- CO6150136A2 CO6150136A2 CO09014466A CO09014466A CO6150136A2 CO 6150136 A2 CO6150136 A2 CO 6150136A2 CO 09014466 A CO09014466 A CO 09014466A CO 09014466 A CO09014466 A CO 09014466A CO 6150136 A2 CO6150136 A2 CO 6150136A2
- Authority
- CO
- Colombia
- Prior art keywords
- adapalene
- use according
- pharmaceutical composition
- benzoyl peroxide
- inflammatory
- Prior art date
Links
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 title abstract 7
- 229960002916 adapalene Drugs 0.000 title abstract 7
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract 4
- 206010000496 acne Diseases 0.000 title abstract 4
- 150000002978 peroxides Chemical class 0.000 title abstract 2
- 230000006378 damage Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 7
- 239000004342 Benzoyl peroxide Substances 0.000 abstract 5
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 abstract 5
- 235000019400 benzoyl peroxide Nutrition 0.000 abstract 5
- 230000002757 inflammatory effect Effects 0.000 abstract 4
- 230000003902 lesion Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000002195 synergetic effect Effects 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
1.- Uso de adapaleno o su sal farmacéuticamente aceptable para la preparación de una composición farmacéutica destinada a ser administrada en combinación o en una aplicación concomitante con peróxido de benzoilo para reducir el número de lesiones de acné. 2.- Uso de acuerdo con la Reivindicación 1 en donde la composición farmacéutica es una combinación fija que comprende, en un medio farmacéuticamente aceptable, (i) por lo menos un compuesto seleccionado de adapaleno y sus sales farmacéuticamente aceptables, y (ii) peróxido de benzoilo. 3.- Uso de acuerdo con la Reivindicación 1 o 2, en el que las lesiones de acné son de tipo inflamatorio y/o no inflamatorio. 4.- Uso de acuerdo con la Reivindicación 3, en el que la reducción del número de lesiones de acné inflamatoria y/o no inflamatoria es por lo menos aproximadamente 40%, preferiblemente por lo menos aproximadamente 50% y más preferiblemente por lo menos aproximadamente 60%. 5.- Uso de acuerdo con la Reivindicación 2 a 4, en el que el adapaleno y el peróxido de benzoilo están presentes en la composición farmacéutica en cantidades sinérgicas. 6.- Uso de acuerdo con a Reivindicación 2 a 5, en el que la composición farmacéutica comprende 0.1% de adapaleno y 2.5% de peróxido de benzoilo. 7.- Uso de acuerdo con una de las Reivindicaciones 2 a 6, en el que la composición farmacéutica es un gel. 8.- Uso de acuerdo con una de las Reivindicaciones 2 a 7, en el que la composición farmacéutica se adapta para aplicación tópica. 9.- Uso de acuerdo con la Reivindicación 1, en el que la dicha composición farmacéutica está en la forma de una composición A que comprende adapaleno, destinada a ser aplicada concomitantemente con una composición B que comprende peróxido de benzoilo. 10.- Uso de acuerdo con la Reivindicación 9, en el que el adapaleno y el peróxido de benzoilo están presentes, respectivamente, en composiciones A y B en cantidades sinérgicas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0652968A FR2903603B1 (fr) | 2006-07-13 | 2006-07-13 | Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne |
| US83349106P | 2006-07-27 | 2006-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6150136A2 true CO6150136A2 (es) | 2010-04-20 |
Family
ID=37763873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09014466A CO6150136A2 (es) | 2006-07-13 | 2009-02-13 | Combinacion de adapaleno y peroxido de benzoilo para tratar lesiones de acne |
Country Status (23)
| Country | Link |
|---|---|
| US (6) | US8129362B2 (es) |
| EP (2) | EP2450035B1 (es) |
| JP (3) | JP2009542779A (es) |
| KR (3) | KR20160120352A (es) |
| CN (1) | CN101541320B (es) |
| AR (1) | AR061989A1 (es) |
| AU (1) | AU2007274288B2 (es) |
| BR (1) | BRPI0713182A8 (es) |
| CA (1) | CA2656456A1 (es) |
| CO (1) | CO6150136A2 (es) |
| CY (1) | CY1121398T1 (es) |
| DK (2) | DK2046318T3 (es) |
| ES (2) | ES2423951T3 (es) |
| FR (1) | FR2903603B1 (es) |
| HU (1) | HUE043502T2 (es) |
| LT (1) | LT2450035T (es) |
| MX (1) | MX2009000319A (es) |
| PL (2) | PL2046318T3 (es) |
| PT (2) | PT2450035T (es) |
| RU (3) | RU2009104949A (es) |
| SI (2) | SI2450035T1 (es) |
| TR (1) | TR201819658T4 (es) |
| WO (1) | WO2008006888A1 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
| FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
| FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
| WO2008092911A1 (en) | 2007-01-30 | 2008-08-07 | Galderma Research & Development | Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris |
| MX2010005516A (es) | 2007-11-30 | 2010-06-02 | Galderma Res & Dev | Composiciones que comprenden al menos un derivado del acido naftoico, de peroxido de benzoilo y al menos un agente filmogeno. |
| MX2010012385A (es) * | 2008-05-16 | 2010-12-02 | Galderma Res & Dev | Regimen de terapia para tratar enfermedades relacionadas al acne. |
| US20130131177A1 (en) * | 2010-02-09 | 2013-05-23 | Galderma Research & Development | Use of a dermatological composition comprising a combination of adapalene and benzoyl peroxide which is intended for the treatment of acne in non-caucasian population with decrease of post-inflammatory hyperpigmentation |
| CA2796412A1 (en) * | 2010-04-29 | 2011-11-03 | Galderma Research & Development | Method for treating scars with adapalene 0.3% |
| FR2969491B1 (fr) * | 2010-12-23 | 2013-07-12 | Galderma Res & Dev | Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo |
| US8563535B2 (en) * | 2011-03-29 | 2013-10-22 | Kamal Mehta | Combination composition comprising benzoyl peroxide and adapalene |
| US20150126608A1 (en) * | 2012-05-25 | 2015-05-07 | Galderma Research & Development | Treatment of preadolescent moderate acne vulgaris |
| MX362520B (es) * | 2012-11-20 | 2019-01-21 | Allergan Inc | Composiciones de dapsona y dapsona/adapaleno topicas y metodos para su uso. |
| CA2944073A1 (en) * | 2014-04-01 | 2015-10-08 | Galderma Research & Development | Combination of adapalene and benzoyl peroxide for treating acne scars |
| EP3171857B1 (en) | 2014-07-25 | 2020-08-19 | Galderma Research & Development | Combination of adapalene and benzoyl peroxide for the treatment of severe acne |
| CN108024980A (zh) * | 2015-08-20 | 2018-05-11 | 索尔-格尔科技有限公司 | 包含过氧化苯甲酰和阿达帕林的用于局部施用的组合物 |
| JP6679299B2 (ja) * | 2015-12-21 | 2020-04-15 | 第一三共ヘルスケア株式会社 | ニキビ治療用外用医薬組成物 |
| KR101986177B1 (ko) * | 2016-10-31 | 2019-06-05 | (주)동구바이오제약 | 여드름 치료용 약물의 생체이용률을 증진시키는 약학적 조성물 |
| WO2018080284A1 (ko) * | 2016-10-31 | 2018-05-03 | (주)동구바이오제약 | 여드름 치료용 약물의 생체이용률을 증진시키는 약학적 조성물 |
| MX2017003003A (es) * | 2017-03-08 | 2018-09-07 | Centro Int De Cosmiatria S A P I De C V | Composición y método para el tratamiento tópico del acné severo. |
| EP3606516A4 (en) * | 2017-03-30 | 2021-01-20 | Scientelle, LLC | METHODS OF TREATMENT AND PREVENTION OF INFECTION |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW203552B (en) * | 1992-02-18 | 1993-04-11 | J Baroody Lloyd | Compositions of clindamycin and benzoyl peroxide for acne treatment |
| FR2727609B1 (fr) | 1994-12-06 | 1997-01-10 | Oreal | Ensemble de distribution pour l'application d'un produit de consistance liquide a pateuse |
| FR2775566B1 (fr) | 1998-03-03 | 2000-05-12 | Oreal | Cupule porte raisin et ensemble de conditionnement pour un produit de maquillage la comportant |
| US6559189B2 (en) * | 1999-04-28 | 2003-05-06 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
| FR2806273B1 (fr) | 2000-03-16 | 2002-10-04 | Oreal | Dispositif de conditionnement et d'application d'un produit cosmetique ou de soin |
| US7820186B2 (en) * | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
| FR2833841B1 (fr) | 2001-12-21 | 2005-07-22 | Galderma Res & Dev | Gel comprenant au moins un retinoide et du peroxyde de benzoyle |
| FR2837101B1 (fr) | 2002-03-12 | 2004-07-02 | Galderma Res & Dev | Utilisation de l'acide 6-[1-adamantyl)-4-methoxyphenyl]-2- naphthoique pour le traitement de desordres dermatologiques |
| GB0301577D0 (en) * | 2003-01-23 | 2003-02-26 | Edko Pazarlama Tanitim Ltd Sti | Topical pharmaceutical and/or cosmetic dispense systems |
| AU2004259030A1 (en) | 2003-07-23 | 2005-02-03 | Xoma Technology Ltd. | Use of XMP-629 for the treatment of acne |
| US20050239723A1 (en) | 2004-04-27 | 2005-10-27 | Amin Avinash N | Compositions and methods useful for treatment of acne |
| US20060128808A1 (en) * | 2004-10-20 | 2006-06-15 | Galderma Research & Development, S.N.C. | Method of using adapalene in acne maintenance therapy |
| AR054805A1 (es) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | Composiciones topicas para el tratamiento de la piel |
| FR2901139B1 (fr) * | 2006-05-17 | 2009-03-20 | Galderma Res & Dev S N C Snc | Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations |
-
2006
- 2006-07-13 FR FR0652968A patent/FR2903603B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-12 EP EP12152317.9A patent/EP2450035B1/en active Active
- 2007-07-12 AU AU2007274288A patent/AU2007274288B2/en active Active
- 2007-07-12 MX MX2009000319A patent/MX2009000319A/es active IP Right Grant
- 2007-07-12 CN CN200780026489.8A patent/CN101541320B/zh active Active
- 2007-07-12 DK DK07787478.2T patent/DK2046318T3/da active
- 2007-07-12 CA CA002656456A patent/CA2656456A1/en not_active Abandoned
- 2007-07-12 ES ES07787478T patent/ES2423951T3/es active Active
- 2007-07-12 ES ES12152317T patent/ES2703505T3/es active Active
- 2007-07-12 KR KR1020167027364A patent/KR20160120352A/ko not_active Application Discontinuation
- 2007-07-12 RU RU2009104949/15A patent/RU2009104949A/ru unknown
- 2007-07-12 PL PL07787478T patent/PL2046318T3/pl unknown
- 2007-07-12 PT PT12152317T patent/PT2450035T/pt unknown
- 2007-07-12 EP EP07787478.2A patent/EP2046318B1/en active Active
- 2007-07-12 KR KR1020147034871A patent/KR20150003917A/ko not_active Application Discontinuation
- 2007-07-12 DK DK12152317.9T patent/DK2450035T3/en active
- 2007-07-12 PT PT77874782T patent/PT2046318E/pt unknown
- 2007-07-12 BR BRPI0713182A patent/BRPI0713182A8/pt not_active Application Discontinuation
- 2007-07-12 HU HUE12152317A patent/HUE043502T2/hu unknown
- 2007-07-12 PL PL12152317T patent/PL2450035T3/pl unknown
- 2007-07-12 LT LTEP12152317.9T patent/LT2450035T/lt unknown
- 2007-07-12 TR TR2018/19658T patent/TR201819658T4/tr unknown
- 2007-07-12 KR KR1020097000572A patent/KR20090028764A/ko not_active Application Discontinuation
- 2007-07-12 WO PCT/EP2007/057207 patent/WO2008006888A1/en active Application Filing
- 2007-07-12 SI SI200732094T patent/SI2450035T1/sl unknown
- 2007-07-12 SI SI200731283T patent/SI2046318T1/sl unknown
- 2007-07-12 JP JP2009518901A patent/JP2009542779A/ja active Pending
- 2007-07-13 AR ARP070103115A patent/AR061989A1/es unknown
- 2007-07-13 US US11/826,364 patent/US8129362B2/en active Active
-
2009
- 2009-01-13 US US12/318,937 patent/US8071644B2/en active Active
- 2009-02-13 CO CO09014466A patent/CO6150136A2/es unknown
-
2011
- 2011-11-14 US US13/296,186 patent/US20120059063A1/en not_active Abandoned
-
2012
- 2012-01-17 US US13/351,986 patent/US8785420B2/en active Active
- 2012-08-29 RU RU2012136952/15A patent/RU2012136952A/ru not_active Application Discontinuation
- 2012-10-18 RU RU2012144414/15A patent/RU2012144414A/ru unknown
-
2013
- 2013-11-22 JP JP2013241729A patent/JP2014040481A/ja active Pending
-
2014
- 2014-06-11 US US14/301,816 patent/US20140296340A1/en not_active Abandoned
-
2015
- 2015-11-06 JP JP2015218597A patent/JP2016029094A/ja active Pending
-
2017
- 2017-03-31 US US15/476,241 patent/US20170202803A1/en not_active Abandoned
-
2019
- 2019-01-24 CY CY20191100091T patent/CY1121398T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6150136A2 (es) | Combinacion de adapaleno y peroxido de benzoilo para tratar lesiones de acne | |
| ES2524320T3 (es) | Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo | |
| AR054805A1 (es) | Composiciones topicas para el tratamiento de la piel | |
| GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| ECSP13012546A (es) | Formulación tópica para un inhibidor de jak | |
| AR090349A1 (es) | Terapia de combinacion para trastornos proliferativos, kit y uso | |
| NI200700320A (es) | Inhibidores de la actividad akt | |
| CO5640076A2 (es) | Composicion farmaceutica que comprende un inhibidor de ibat para el tratamiento o profilaxis del estreñimiento | |
| AR059066A1 (es) | Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf) | |
| AR065704A1 (es) | Composiciones y equipos para el tratamiento de la influenza | |
| CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
| AR078846A1 (es) | Composicion para el tratamiento de la enfermedad de alzheimer | |
| CR11418A (es) | Trans-clomifeno para el sindrome metabolico | |
| AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
| CU20120171A7 (es) | Triazolopiridinas sustituidas | |
| AR085662A1 (es) | Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia | |
| CO6382133A2 (es) | Metodo para tratar o prevenir la trombosis usando etexilato de dabigatran o una sal del mismo con una eficacia mejorada sobre la terapia con warfarina convencional | |
| AR084216A1 (es) | Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k e inhibidor de mek, kit | |
| AR065316A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologiamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
| ECSP13012538A (es) | Combinaciones que contienen n-(2-arilamino)arilsulfonamida sustituida | |
| BRPI0607003A2 (pt) | forma de dosagem com liberação sustentada e método para liberação sustentada de um composto de pirazina substituìda | |
| AR081082A1 (es) | Composiciones organicas para tratar enfermedades relacionadas con beta-enac | |
| CL2009001841A1 (es) | Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto. | |
| AR057866A1 (es) | Composiciones que comprenden por lo menos un derivado de acido naftoico y por lo menos un compuesto del tipo de polimeros de poliuretano o sus derivados, un procedimiento para prepararlos y usos de los mismos | |
| CL2010000524A1 (es) | Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales. |